Cargando…
Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
We characterized the fatty acid profiles in the erythrocyte membrane of pediatric patients with cystic fibrosis (CF) receiving highly concentrated docosahexaenoic acid (DHA) supplementation (Tridocosahexanoin-AOX(®) 70%) at 50 mg/kg/day (n = 11) or matching placebo (n = 11) for 12 months. The mean a...
Autores principales: | Ayats-Vidal, Roser, Bosque-García, Montserrat, Cordobilla, Begoña, Asensio-De la Cruz, Oscar, García-González, Miguel, Castro-Marrero, Jesús, López-Rico, Irene, Domingo, Joan Carles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253750/ https://www.ncbi.nlm.nih.gov/pubmed/37297899 http://dx.doi.org/10.3390/jcm12113704 |
Ejemplares similares
-
Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
por: Castillo Salinas, Félix, et al.
Publicado: (2022) -
Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
por: Castillo, Félix, et al.
Publicado: (2021) -
Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017) -
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017) -
Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)